Introduction
Current guidelines recommend that antihypertensive treatment should be guided by a patient's future risk of cardiovascular disease, cardiovascular mortality, or total mortality. 1 The guidelines further specify that risk estimates over 10 years should form the basis for a treatment decision. A range of studies have suggested that the average ambulatory blood pressure (BP) recorded during 24 h provides information superior to conventional BP measured in a doctor's office. [2] [3] [4] Further, recent ESC Guideline recommends use of the average ambulatory BP, though the ESC endorsed SCORE chart is based on office BP. 1, 3 Several studies have attempted to identify particularly important periods for prognosis in the 24-h BP profiles. [5] [6] [7] [8] [9] [10] [11] These studies concluded that night-time BP is of particular importance. The studies, which suggested superiority of ambulatory measurements, have all relied on Cox regression analyses where office BP was examined along with ambulatory BP, and daytime BP along with night-time BP. These studies have found ambulatory BP to provide higher hazard ratios than office BP. It is generally not possible to derive from such a result that ambulatory BP also improves long-term predictions for individual persons. The long-term prediction of a person depends not only on the association of BP with cardiovascular event but also on the competing risk of non-cardiovascular mortality. Second, when two correlated variables such as ambulatory BP and office BP are compared in a Cox model generally one of these variables will appear more important than the other, but this result does not necessarily reflect a significant more important effect on longterm prediction. It is known that large hazard ratios are needed to improve risk predictions significantly. [12] [13] [14] [15] [16] It is thus necessary to go beyond standard Cox regression results that state a significant hazard ratio, and to calculate the long-term risk predictions of individuals. In this article, we aim to assess if the associations of BP seen in Cox regression for cardiovascular outcomes translate into improvements of 10-year risk predictions. Improvements are assessed on the personspecific level where individualized 10-year absolute risk predictions are compared with the actual outcome of the individuals after 10 years. To our knowledge, no studies have compared office BP and multiple ambulatory BP measurements by considering personspecific absolute risks. The important clinical question of whether ambulatory BP adds prognostic information to office BP and whether night-time measurements are particularly important is therefore unanswered.
To investigate these questions, we have therefore used a large dataset of multiple general population cohorts to re-examine the added value of the average systolic ambulatory BP over systolic office BP and the added value of the average systolic night-time BP compared with average systolic daytime BP. We have employed recent developments in statistical techniques for the setting which properly accounts for non-cardiovascular mortality. [17] [18] [19] 
Methods

Study population
This study is based on a previously described dataset consisting of 12 general population studies. 20 At enrolment, all studies recorded office BP and ambulatory BP during a 24-h period. Further, all studies included information on baseline cardiovascular risk factors and follow-up information on cardiovascular events. We considered only six cohorts, which had sufficient follow-up to allow within cohort assessment of 10-year risks. In accordance with the guidelines, 3 we excluded subjects if less than 70% of the daytime ambulatory BP had been recorded (n = 394), if nighttime ambulatory BP had not been recorded (n = 1581), if less than 70% of the night-time ambulatory BP had been recorded (n = 323), or if less than 70% of the 24-h ambulatory BP measurements had been recorded (n = 1774). We further excluded persons if office BP had not been measured (n = 247), if no information was available on the use of antihypertensive drugs (n = 31) or fatal and non-fatal events (n = 69), or if the cause of death was unknown (n = 44). Thus, the number of persons included in our analyses totaled 7927. Baseline cardiovascular risk factors were obtained by interviews, 23, 24 questionnaires, 9,21-23 and/or medical records. 6 Information on treatment with antihypertensive drugs were recorded at the time of the initial BP measurements.
Outcome
Vital status at the end of follow-up and incidences of fatal and non-fatal complications were obtained as described elsewhere. 6, 9, [21] [22] [23] [24] The primary outcomes of interest were cardiovascular mortality and combined cardiovascular events consisting of both fatal and non-fatal cardiovascular complications. Combined fatal and non-fatal cardiovascular events were specified as cerebrovascular death and non-fatal stroke; coronary events (death from ischaemic heart disease, sudden death, non-fatal myocardial infarction, or coronary revascularization); and cardiac events defined as the coronary events and fatal or non-fatal heart failure. As secondary outcomes, we individually analysed each of the above-mentioned fatal and non-fatal cardiovascular events. 
Blood pressure measurements
Statistical methods
Person-specific averages of the first two systolic office BP recordings were calculated; if available the measurements recorded in the sitting position were used else measurements in the supine position were used. Person-specific averages of the systolic ambulatory BP were calculated separately for all 24 h, daytime, and night-time recordings. Hypertension was defined when either the average systolic daytime ambulatory BP was greater than 135 mmHg or the average systolic night-time ambulatory BP was greater than 120 mmHg. Nocturnal hypertension was defined when the average systolic daytime ambulatory BP was less than 135 mmHg and the average systolic night-time ambulatory BP was greater than 120 mmHg.
The median follow-up time was estimated by the reverse KaplanMeier method. 25 Missing information on history of cardiovascular diseases (n = 1), diabetes (n = 4), current smoking (n = 34) and drinking (n = 604) habits, body mass index (n = 4), and total serum cholesterol level (n = 131) were imputed by the most likely value in the person's cohort.
In each cohort, two cause-specific Cox regression analyses were applied and combined into 10-year absolute risk predictions:
18,26,27 one for cardiovascular end points and one for non-cardiovascular mortality (formula details in Supplementary material online). 27 Cox regression Person-specific predicted 10-year risks and changes in predicted 10-year risks were summarized using quantiles. By using the inverse probability of censoring weighting technique, 28 quantiles of changes in predicted 10-year risks were obtained retrospectively and conditional on outcome after 10 years. Results are presented as the median difference of predicted risks and the corresponding 1st quartile (Q1) and 3rd quartile (Q3). We used time-dependent area under the receiver operating characteristic curve (AUC) for competing risks to assess predictive performance (discriminative ability). 19 AUC is the probability that a subject who experiences the event (cardiovascular mortality, cardiovascular events) received a higher predicted 10-year risk compared with a subject who either died due to non-cardiovascular causes or were alive 10 years after the BP measurements. Differences in AUC were used to assess the effect of adding 24-h ambulatory BP to office BP and adding night-time ambulatory BP to daytime ambulatory BP. Inverse variance fixed-effect meta-analyses were applied to average differences in AUC across the six cohorts. Consistency of difference in AUC across the six cohorts was assessed Cochran's Q-test of heterogeneity.
We conducted additional analyses of the 4505 persons with no missing values on any BP during the 24 h. Person-specific averages of ambulatory BP were calculated separately for each hour during the 24 h. We further divided the daytime and night-time period into each three periods of 3-4 h intervals and calculated the person-specific average of the ambulatory BP for each period. In Cox regression models, we included either office BP or both office BP and hour/period BP. Analyses were adjusted for conventional risk factors as specified previously. All analyses were performed with the R statistical software version 3.2.2. 29 
Ethics
The data were anonymous, ethical approval not relevant. All the original studies were ethically approved.
Results
All participants
The study population consisted of 7927 persons from six different population studies. During the follow-up period, a total of 563 participants died from cardiovascular events and 758 died from noncardiovascular events. Further, a total of 1173 were diagnosed with a fatal or non-fatal cardiovascular event. The median follow-up period ranged from 9.1 years (Q1-Q3, 9.0-9.2) in the Montevideo cohort to 17.3 years (Q1-Q3, 17.2-17.6 ) in the Noorderkempen cohort. Subject characteristics are summarized in Table 1 . Figure 1 shows the changes of person-specific 10-year risk predictions when 24-h ambulatory BP is added to office BP and conventional risk factors. For the great majority of persons, the information provided by 24-h ambulatory BP had almost no effect. For 90% of the persons, the predicted 10-year risk of cardiovascular mortality (cardiovascular events) changed by less than 2.5% (5.7%). Figure 1D shows that the median difference (Q1-Q3) of person-specific risks was 0.1% (-1.8 to 3.0%) in persons who suffered cardiovascular diseases and -0.4% (-2.6 to 1.5%) in persons who died due to noncardiovascular causes within 10 years. The median change of predicted risks was -0.1% (-1.1 to 0.4%) in persons who were event-free 10 years after the BP measurements. Figure 2 shows the changes in person-specific 10-year cardiovascular risk predictions when night-time ambulatory BP is added to daytime ambulatory BP and conventional risk factors. For 90% of the persons, the 10-year risk prediction of cardiovascular mortality (cardiovascular events) changed by less than 1.8% (3.5%). The median difference (Q1-Q3) of person-specific risks was 0.03% (-1.0 to 1.5%) in subjects who suffered cardiovascular diseases and -0.01% (-0.9 to 0.9%) in subjects who died due to non-cardiovascular causes within 10 years ( Figure 2D) . The median change of predicted risks was -0.02% (-0.5 to 0.2%) in subjects who were event-free 10 years after the BP measurements. Figure 3 shows the changes in AUC obtained by adding 24-h ambulatory BP to office BP. Including 24-h ambulatory BP significantly increased AUC for 10-year predictions of cardiovascular mortality (difference in AUC, 0.65%; 95% CI, 0.22-1.08%; P ¼ 0.003). For cardiovascular events, adding 24-h ambulatory BP to office BP also significantly increased the AUC, but the gain was likewise small (difference in AUC, 1.33%; 95% CI, 0.83-1.84%; P < 0.001). Test of heterogeneity indicated consistent AUC differences across the six Figure 1 Person-specific 10-year absolute risk predicted using office blood pressure and 24-h ambulatory blood pressure. Ten-year person-specific absolute risks of cardiovascular mortality (A and C) and cardiovascular events (B and D) predicted using office blood pressure (BP) and 24-h ambulatory BP. (A and B) show person-specific predictions based on both office BP and 24-h ambulatory BP vs. only office BP. Boxplots in (C) and (D) show 5, 25, 50, 75, and 95% quantiles of the person-specific differences in predicted absolute risks based on both office BP and 24-h ambulatory BP vs. only office BP conditional on outcome after 10 years.
Office blood pressure or ambulatory blood pressure for the prediction cohorts for both cardiovascular mortality (P = 0.40) and cardiovascular events (P = 0.52). Figure 4 shows differences in AUC for 10-year outcomes comparing predictions using night-time ambulatory BP to predictions using only daytime ambulatory BP. For both outcomes, zero differences indicate that the discrimination ability obtained by including night-time ambulatory BP was similar to that obtained by including daytime ambulatory BP. Also adding both daytime and night-time ambulatory BP did not significantly improve AUC for cardiovascular mortality (difference in AUC, 0.10%; 95% CI, -0.08 to 0.29%; P = 0.28) and cardiovascular events (difference in AUC, 0.15%; 95% CI, -0.06 to 0.35%; P = 0.16). Test of heterogeneity indicated consistent AUC differences across the six cohorts for both cardiovascular mortality (P = 0.89) and cardiovascular events (P = 0.82). Corresponding results for individual cohorts and secondary outcomes are shown in Supplementary material online (Supplementary material online, Figures S1-S6) .
Results of cause-specific Cox regression analyses are presented in Supplementary material online, Tables S1-S4. These analyses indicated that statistical association between the BP variables and cause-specific hazard rates depend on the outcome of interest and antihypertensive treatments status.
Subgroups
We summarized 10-year predicted risks of any cardiovascular in subgroups defined by age, known history of cardiovascular diseases, known diabetes, ongoing antihypertensive treatment, hypertension, Figure 2 Person-specific 10-year absolute risk predicted using daytime ambulatory blood pressure and night-time ambulatory blood pressure.
Ten-year person-specific absolute risks of cardiovascular mortality (A and C) and cardiovascular events (B and D) predicted using daytime ambulatory blood pressure (BP) and night-time ambulatory BP. (A and B) show person-specific predictions based on both daytime and night-time ambulatory BP vs. only daytime ambulatory BP. Boxplots in (C) and (D) show 5, 25, 50, 75, and 95% quantiles of the person-specific differences in predicted absolute risks based on both daytime and night-time ambulatory BP vs. only daytime ambulatory BP conditional on outcome after 10 years. Figures S7 and S8) . For analyses of daytime and night-time ambulatory BP, substantial deviations from the overall results were seen for subjects with nocturnal hypertension. The predicted risks were elevated for 75% of the persons in this subgroup when night-time ambulatory BP was included. However, the 10-year outcomes reveal that also persons who were event-free and persons who died due to noncardiovascular causes received a higher risk prediction.
. . and nocturnal hypertension (see Supplementary material online,
Additional analyses of 24-h ambulatory blood pressure
We summarized predicted 10-year risks of the two primary outcomes at each hour during the 24 h in subgroups defined by intervals of office BP (see Supplementary material online, Figures S9 and S10) . For all subgroups, a model containing both office BP and the hourly BP provided risk predictions similar to a model containing only office BP.
We further evaluated the difference in AUC of a model containing only office BP and a model containing both office BP and average BP in different periods during daytime and during night-time (see Supplementary material online, Figures S11 and S12) . In general, differences in AUC were not significant difference from zero for any of the periods.
Discussion
The main result of this study is that for a general population the prognostic information for assessing the 10-year risk of cardiovascular complications is not substantially improved by adding multiple BP measurements during daytime and during night-time. These findings 
were consistent across six population cohorts for fatal and non-fatal cardiovascular events.
The current cohort of studies has previously been used to argue for an importance of night-time BP measurements. 7, 8 We were able to reproduce the previous results on the hazard scale obtained by cause-specific Cox regression, and the new insights of this study were obtained by considering person-specific predictions for 10-year absolute risks of cardiovascular outcomes. Several population studies 5 and meta-analyses 4 have indicated 24-h ambulatory BP to provide additional prognostic information compared with office BP. Night-time ambulatory BP has also been reported to be superior to daytime ambulatory BP for determining cardiovascular mortality. 5, 7, 9 To understand the discrepancy with the current study it is important to note that the studies reporting superiority of ambulatory BP and night-time BP did only evaluate statistical significance of hazard ratios and not accuracy of long-term personspecific predictions. Several limitations are related to an approach based on statistical significance. [12] [13] [14] [15] [16] Further, daily activities cause greater variance in multiple ambulatory BP measurements than in office BP. This greater variance may cause greater bias and loss of statistical power for effects of ambulatory BP compared with office BP.
Our results demonstrate that even though Cox regression shows highly significant hazard ratios the effects do not translate into significant improvements for long-term predictions.
The results of Figure 1 indicate that in general absolute risks obtained by adding 24-h ambulatory BP to office BP were similar to absolute risks obtained by office BP alone. Thus for the great majority of persons the information used to assess a person's prognosis is not substantially changed when information on 24-h ambulatory BP is added. Similar results regarding daytime and night-time ambulatory BP were observed (Figure 2) . Since a particular importance could be anticipated for night-time BP in persons with diabetes and in persons Figure 4 Differences in area under the ROC curve using daytime ambulatory blood pressure and night-time ambulatory blood pressure. For each outcome the first row shows the area under the ROC curve (AUC) for 10-year outcome (%) obtained with predictions obtained by combined cause-specific Cox regression including daytime ambulatory blood pressure (BP) and conventional risk factors. The other two rows show differences in AUC (%) for corresponding predictions including night-time ambulatory BP instead of daytime ambulatory BP and for predictions including both daytime and night-time ambulatory BP together with conventional risk factor.
with nocturnal hypertension we examined these subgroups in detail. We found no added value of night-time ambulatory BP in persons with diabetes and a minimal value in persons with nocturnal hypertension, the latter reflects that these persons also have high normal daytime BP. Due to a shortage of persons with established diabetes and isolated nocturnal hypertension, it is possible that night-time BP can be important when evaluating such patient groups.
From an event-prevention perspective, prognostic models must accurately rank persons according to predicted risks of cardiovascular events. Discrimination ability in this study was quantified by means of time-dependent AUCs. In the case with competing risks, the timedependent AUC can be interpreted as the probability that a higher risk is predicted to persons who have the cardiovascular event prior to the 10th year compared with persons who either die due to other causes without the cardiovascular event or are event-free and alive until the 10th year. The findings in this study suggest that ambulatory BP increases the discrimination ability of office BP for assessing the risk of cardiovascular events (Figure 3) . However, as AUC changed by less than 1% the advantage of ambulatory BP over office BP applies to only a small percentage of persons. It is not possible from the current study to identify whether these persons comprise a specific subgroup. The findings in Figure 4 indicate that night-time ambulatory BP does not add additional discrimination information to daytime ambulatory BP. Thus, obtaining information on night-time BP does not increase the information used to distinguish persons potentially developing a cardiovascular complication within 10 years from persons not developing the cardiovascular event.
In conclusion, this study demonstrates that for the great majority of persons ambulatory BP and office BP provide similar predictive values for estimation of long-term risk of fatal and non-fatal cardiovascular events. It was further demonstrated that information from night-time ambulatory BP measurements does not improve discrimination ability beyond that of daytime ambulatory BP. The results of the current study have implications for requirements to ambulatory BP monitoring. For the purpose of screening an otherwise healthy population sufficient accuracy can be achieved with office BP.
Limitations
The strength of this study is the inclusion of large cohorts and the availability of long-term follow-up on cardiovascular events. The inherent weakness is related to the nature of population surveys. Participation by invitation is not complete and in general the less healthy are unlikely to participate. Thus, the participants included may be healthier than the general population in these countries. Another important limitation is the relative shortage of patients with established hypertensive diseases. Thus, ambulatory BP as well as night-time BP can have importance in selected populations.
Supplementary material
Supplementary material is available at European Heart Journal online.
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